Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmadata Oy
OY
Active
Y-tunnus 0761186-7
Mechelininkatu 1A, 00180
Helsinki
Computer programming activities
· NACE 6210
Est. 1989
38 employees
www.pharmadata.fi
Watchlist
Share
Finland
/
Companies
/
Computer programming activities
/
Pharmadata Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
3M
5M
8M
10M
7M
2021
8M
2022
8M
2023
8M
2024
9M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
-1M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
7 359
7 697
7 874
8 443
9 022
Staff expenses
−2 866
−2 500
−3 216
−3 103
−2 782
EBITDA
129
73
−665
−274
−199
Depreciation & amort.
−88
−74
−65
−136
−135
EBIT
41
−0
−730
−410
−333
Net financials
14
−29
−1
−25
−25
Profit before tax
54
−29
−732
−435
−359
Tax
11
14
−0
−7
−0
Net profit
43
−43
−732
−428
−359
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
3 300
3 052
2 829
2 938
2 986
Equity
2 162
2 019
1 112
883
524
Long-term debt
—
—
0
500
750
Short-term debt
1 138
1 033
1 717
1 555
1 712
Total debt
1 138
1 033
1 717
2 055
2 462
Financial ratios
5-year trend
EBITDA margin
-2.2%
This company
15.8%
Market median
-114% vs market
2021
2025
Equity ratio
17.6%
This company
38.2%
Market median
-54% vs market
2021
2025
Return on equity
-68.4%
This company
18.4%
Market median
-472% vs market
2021
2025
Net profit margin
-4.0%
This company
8.1%
Market median
-149% vs market
2021
2025
Asset turnover
3.02×
This company
1.12×
Market median
+170% vs market
2021
2025
Debt / equity
4.69×
This company
0.62×
Market median
-656% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pharmadata Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network